All News
Filter News
Found 772,236 articles
-
American Diabetes Association Release: World Diabetes Day Focuses On Preventing Lower Limb Amputations
11/14/2005
-
Cytokinetics, Inc. To Present At The Credit Suisse First Boston Annual Health Care Conference
11/14/2005
-
Zimmer Holdings Inc. To Present At The Credit Suisse First Boston Health Care Conference
11/14/2005
-
Vertex Pharmaceuticals Incorporated Announces Webcast Of Its Presentation At Credit Suisse First Boston's Health Care Conference
11/14/2005
-
AMERIGROUP Corporation To Present At The Credit Suisse First Boston Health Care Conference On November 17th
11/14/2005
-
Edwards Lifesciences To Present At Credit Suisse First Boston Annual Healthcare Conference
11/14/2005
-
US FDA Warns About Johnson & Johnson Patch Hormone Levels
11/11/2005
-
U.S. District Court Grants Abbott Laboratories's Request For A Preliminary Injunction Against Biaxin(R) XL Generics; Andrx Corporation Shares Drop 8% On Ruling
11/11/2005
-
Idenix Pharmaceuticals, Inc. Release: Valopicitabine (NM283) Combined With Pegylated Interferon Demonstrated Significantly Greater Suppression Of Hepatitis C Virus (HCV) Replication In Treatment-Refractory Patients Compared To Retreatment With Ribavirin P
11/11/2005
-
Vertex Pharmaceuticals Incorporated Release: AASLD Presentations Support The Initiation Of A Broad Phase II Program With VX-950, An Investigational Oral HCV Protease Inhibitor
11/11/2005
-
Genetic Find Stirs Debate On Race-Based Medicine
11/11/2005
-
Pharmaxis Ltd Completes Capital Raising AUD$87 Million (US$63 Million)
11/11/2005
-
Sangamo BioSciences, Inc. To Sell Shares Worth $20.5 Million
11/11/2005
-
Proposed Condom Labels Warn Against Spermicide
11/11/2005
-
St. Jude Medical Obtains Foreign Antitrust Clearance To Acquire Advanced Neuromodulation Systems
11/11/2005
-
Bacterium, Gene Play Roles In Elderly Vision Loss
11/11/2005
-
Loneliness Could Be In Your Genes
11/11/2005
-
New "Eye Movement" Test May Help Treat Fetal Alcohol Syndrome
11/11/2005
-
Viventia Biotech Inc. Receives Fast Track Designation From The FDA For Proxinium(TM) In Head & Neck Cancer
11/11/2005
-
ImClone Systems CEO Daniel S. Lynch Resigns, Interim Chief Named
11/11/2005